Mersana Therapeutics
MRSN
MRSN
130 hedge funds and large institutions have $1.53B invested in Mersana Therapeutics in 2020 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 50 increasing their positions, 23 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
117% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 23
59% more funds holding
Funds holding: 82 → 130 (+48)
0.38% more ownership
Funds ownership: 3.53% → 3.91% (+0.38%)
Holders
130
Holding in Top 10
9
Calls
$7.97M
Puts
$1.35M
Top Buyers
| 1 | +$152M | |
| 2 | +$138M | |
| 3 | +$90.1M | |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$80.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$67M |
Top Sellers
| 1 | -$93.7M | |
| 2 | -$32.2M | |
| 3 | -$27.6M | |
| 4 |
VA
VR Adviser
New York
|
-$15.3M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$13.8M |